Bicycle Therapeutics PLC reports results for the quarter ended in March - Earnings Summary

Bicycle Therapeutics

05/05/2022 14:02

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of 93 cents​​ per share for the quarter ended in March. The
mean expectation of twelve analysts for the quarter was for a
loss of 68 cents per share.
    * Revenue rose 113.5% to $3.86 million from a year ago; 
analysts
expected $4.41 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of 93 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bicycle Therapeutics PLC shares had fallen by 47.8% this
quarter and lost 62.3% so far this year.
    * The company reported a quarterly loss of $27.56 million.
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $65.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 01:02 p.m.  ​All
figures in US dollars unless otherwise stated